Nivolumab

AUG 18, 2026 · PHASE 2 TRIAL

Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)

ClinicalTrials.gov

This is a Phase 2, single-arm feasibility study with no results yet posted; it is designed to evaluate concurrent SBRT and immunotherapy but carries no outcome data to assess efficacy or safety.

AUG 18, 2026 · PHASE 2 TRIAL

Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer

ClinicalTrials.gov

Phase 2 registry record with completed enrollment but no results posted; cannot assess efficacy or safety from registration alone.

AUG 18, 2026 · PHASE 1/2 TRIAL

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

ClinicalTrials.gov

This is an ongoing Phase 1/2 trial registration with no results reported; it describes planned safety and tolerability endpoints in a combination drug study for advanced solid tumors.